Edit
Stanmore Implants
http://www.stanmoreimplants.com/Last activity: 26.01.2012
Active - Reference to Stryker CMF
Stanmore Implants is an orthopaedic company focused on saving and restoring the function of limbs and joints. The company is developing novel ITAP technology for attaching prosthetics to the skeletons’ of amputees. Stanmore Implants was formed in 1996 as a vehicle for the further development of the custom orthopaedic implant service operated by University College London’s Centre for Biomedical Engineering.
Location: United Kingdom, England, London
Total raised: $6.52M
Investors 2
| Date | Name | Website |
| - | Abingworth... | abingworth... |
| - | Norgine Ve... | norgineven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.07.2011 | - | $6.52M | Imperial I... |
Mentions in press and media 6
| Date | Title | Description |
| 26.01.2012 | Boston Scientific lauds NICE results from the U.K. | Regulatory Roundup | Boston Scientific Corp. (NYSE:BSX) lauded a new guidance released by the research arm of the U.K.’s National Health Service, the country’s publicly funded health care system. The National Institute for Health & Clinical Excellence issue... |
| 12.01.2012 | China’s med-tech market to grow 17% in 2012 | MassDevice.com On Call | MASSDEVICE ON CALL —China’s medical device market is set to grow 17% in 2012, according to a Citigroup hospital survey. Major medical equipment in the Chinese market include medical monitors and life support, diagnostic imaging, in vitro di... |
| 06.01.2012 | FDA clears Smith & Nephew’s Pico pocket NPWT device | Regulatory Roundup | Smith & Nephew (NYSE:SNN) won a nod from the FDA for its Pico negative-pressure wound therapy system. The British orthopedics giant’s wound care division said the FDA cleared the device for use in the home and in hospitals. It’s already... |
| 25.07.2011 | Cardiac medical device firm Sunshine Heart raises $4.6 million | Funding Roundup | Cardiac medical device firm Sunshine Heart (ASX:SHC) raised $4.6 million by selling 115 million shares in a private placement with institutional investors in the U.S. and Canada at 4 cents per share. The Eden Prairie, Minnesota-based compan... |
| 22.07.2011 | Stanmore Implants Receives £4m Equity Investment from Imperial Innovations Group | Stanmore Implants, an Elstree, UK-based specialist in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, has received a £4m equity investment from Imperial Innovations Group plc (AIM: IVO) Follo... |
| 05.07.2011 | FDA clears juvenile femur replacement that can “grow” with a patient | Stanmore Implants won FDA clearance for an extendible femur implant that can "grow" as the patient does, without the need for surgery, anesthesia or sedation. The Juvenile Tumour System replaces large portions of the femoral bone ... |